<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 7 Issue 2</issue_number>
<issue_period>2016 (April - June)</issue_period>
<title>ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF ABIRATERONE ACETATE IN PHARMACEUTICAL FORMULATION BY UV AND RP-HPLC </title>
<abstract>A simple, specific and accurate reverse phase high performance liquid chromatographic method was developed for the determination Abiraterone Acetate in pharmaceutical dosage form. The column used was Hypersil ODS C18 (4.6 x 150mm, 5 mm,) in isocratic mode, with mobile phase containing phosphate buffer adjusted the pH-3.0 with orthophosphoric acid and Acetonitrile ratio of (50%:50%) the flow rate was 1.0 mL/ min and eluents was monitored at 254nm. The retention time Abiraterone was 4.858 min. The linearity for Abiraterone was in the range of 10-30 µg/ml respectively. The recovery of Abiraterone was found to be 99.5%, respectively. The proposed method was validated and successfully applied to the estimation of Abiraterone in tablet dosage form. Mass and FTIR analysis performed to determine Abiraterone Acetate in pharmaceutical dosage form.</abstract>
<authors>ARUN KUMAR KUNA*, S. GANAPATY AND G.V. RADHA</authors>
<keywords>Abiraterone Acetate, RP-HPLC, Validation</keywords>
<pages>57-61</pages>
</article>
</Journal>
